documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
669 rows where agency_id = "FDA", document_type = "Notice" and posted_year = 2007 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2007-D-0257-0001 | FDA | None FDA-2007-D-0257 | See Document ID FDA-2007-D-0257-0003 | Notice | 2007-12-28T00:00:00Z | 2007 | 12 | 2008-05-21T20:22:03Z | 0 | 1 | 090000648042b1c1 | ||||
| FDA-2007-N-0313-0001 | FDA | None FDA-2007-N-0313 | Maximizing the Public Health Benefit of Adverse Event Collection Throughout a Product's Marketed Life Cycle; Public Workshop; Request for Comments | Notice | NM-Notice of Meeting | 2007-12-26T05:00:00Z | 2007 | 12 | 2007-12-21T05:00:00Z | 2008-03-01T04:59:59Z | 2008-08-15T01:38:12Z | 0 | 0 | 090000648042b70a | |
| FDA-2007-N-0441-0001 | FDA | None FDA-2007-N-0441 | Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions; Correction | Notice | Correction | 2007-12-26T05:00:00Z | 2007 | 12 | 2025-08-19T20:11:21Z | E7-24914 | 0 | 0 | 090000648042dda7 | ||
| FDA-2007-C-0044-0001 | FDA | None FDA-2007-C-0044 | DSM Nutritional Products, Inc.; Filing of Color Additive Petition; Correction | Notice | NCR-Notice of Correction | 2007-12-26T05:00:00Z | 2007 | 12 | 2007-12-21T05:00:00Z | 2026-01-08T20:18:17Z | 0 | 0 | 0900006480429648 | ||
| FDA-2007-N-0152-0001 | FDA | None FDA-2007-N-0152 | Health Claims and Qualified Health Claims; Dietary Lipids and Cancer, Soy Protein and Coronary Heart Disease, Antioxidant Vitamins and Certain Cancers, and Selenium and Certain Cancers; Reevaluation; Opportunity for Public Comment | Notice | N-Notice | 2007-12-21T05:00:00Z | 2007 | 12 | 2007-12-21T05:00:00Z | 2008-02-20T04:59:59Z | 2008-07-08T18:53:47Z | 0 | 0 | 090000648042a409 | |
| FDA-2007-M-0452-0001 | FDA | None FDA-2007-M-0452 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-09T22:48:41Z | E7-24620 | 0 | 0 | 090000648042dec7 | |
| FDA-2007-M-0273-0001 | FDA | None FDA-2007-M-0273 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-09T21:15:57Z | E7-24620 | 0 | 0 | 090000648042b3c6 | |
| FDA-2007-M-0453-0001 | FDA | None FDA-2007-M-0453 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-10T00:23:52Z | E7-24620 | 0 | 0 | 090000648042ded7 | |
| FDA-2007-M-0325-0001 | FDA | None FDA-2007-M-0325 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-10T04:01:42Z | E7-24620 | 0 | 0 | 090000648042b804 | |
| FDA-2007-N-0382-0001 | FDA | None FDA-2007-N-0382 | Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting | Notice | Meeting | 2007-12-19T05:00:00Z | 2007 | 12 | 2025-08-19T15:55:54Z | E7-24629 | 0 | 0 | 090000648042d70f | ||
| FDA-2007-M-0397-0001 | FDA | None FDA-2007-M-0397 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-12T23:22:10Z | E7-24620 | 0 | 0 | 090000648042d84e | |
| FDA-2007-M-0224-0001 | FDA | None FDA-2007-M-0224 | FDA | Notice | NAL-Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2008-04-04T00:35:16Z | 0 | 0 | 090000648042ae2e | ||
| FDA-2007-M-0223-0001 | FDA | None FDA-2007-M-0223 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-09T23:33:10Z | E7-24620 | 0 | 0 | 090000648042ae1d | |
| FDA-2007-M-0093-0001 | FDA | None FDA-2007-M-0093 | Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications | Notice | Notice of Approval | 2007-12-19T05:00:00Z | 2007 | 12 | 2007-12-19T05:00:00Z | 2026-01-13T00:37:18Z | E7-24620 | 0 | 0 | 0900006480429d20 | |
| FDA-2007-D-0306-0002 | FDA | None FDA-2007-D-0306 | International Conference on Harmonisation; Draft Guidance on Q4B | Notice | NAD-Notice of Availability of Data | 2007-12-18T05:00:00Z | 2007 | 12 | 2007-12-14T05:00:00Z | 2008-02-16T04:59:59Z | 2009-01-12T16:01:41Z | 0 | 0 | 090000648042b66c | |
| FDA-2007-D-0200-0002 | FDA | None FDA-2007-D-0200 | International Conference on Harmonisation; Draft Guidance on Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions; Annex on Test for Extractable Volume of Parenteral Preparations General Chapter; Availibilty | Notice | NAD-Notice of Availability of Data | 2007-12-18T05:00:00Z | 2007 | 12 | 2007-12-14T05:00:00Z | 2008-02-16T04:59:59Z | 2008-05-28T19:58:35Z | 0 | 0 | 090000648042abc7 | |
| FDA-2005-D-0013-0008 | FDA | Collection of Platelets by Automated Methods FDA-2005-D-0013 | FDA | Notice | NAD-Notice of Availability of Data | 2007-12-18T05:00:00Z | 2007 | 12 | 2007-12-14T05:00:00Z | 2008-12-16T04:59:59Z | 2008-04-11T23:46:16Z | 0 | 0 | 090000648043e53f | |
| FDA-2007-N-0319-0001 | FDA | None FDA-2007-N-0319 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Health and Diet Survey | Notice | 30 Day Proposed Information Collection | 2007-12-17T05:00:00Z | 2007 | 12 | 2007-12-13T05:00:00Z | 2008-01-15T04:59:59Z | 2025-07-18T17:30:47Z | E7-24123 | 0 | 0 | 090000648042b7c7 |
| FDA-2007-N-0441-0002 | FDA | None FDA-2007-N-0441 | Agency Emergency Processing Under the Office of Management and Budget Review; Certification to Accompany Drug, Biological Product, and Device Applications or Submissions | Notice | General Notice | 2007-12-12T05:00:00Z | 2007 | 12 | 2007-12-12T05:00:00Z | 2007-12-18T04:59:59Z | 2025-08-19T20:24:09Z | 07-6023 | 0 | 0 | 090000648042dda4 |
| FDA-2007-N-0272-0002 | FDA | None FDA-2007-N-0272 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Presubmission Conferences, New Animal Drug Applications and Supporting Regulations and Guidance 152, and Form FDA 356V | Notice | 30 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-01-11T04:59:59Z | 2025-07-23T19:31:13Z | E7-23998 | 0 | 0 | 090000648042b3bd |
| FDA-2007-N-0220-0002 | FDA | None FDA-2007-N-0220 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Guidance for Industry on Pharmacogenomic Data Submissions; Extension | Notice | 30 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-01-11T04:59:59Z | 2025-08-07T22:57:55Z | E7-23996 | 0 | 0 | 090000648042adfb |
| FDA-2007-N-0383-0003 | FDA | None FDA-2007-N-0383 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Radioactive Drug Research Committees | Notice | 30 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-10T05:00:00Z | 2008-01-11T04:59:59Z | 2025-08-11T16:06:25Z | E7-23977 | 0 | 0 | 090000648042d750 |
| FDA-2007-C-0044-0002 | FDA | None FDA-2007-C-0044 | DSM Nutritional Products, Inc.; Filing of Color Additive Petition | Notice | NFL-Notice of Filing | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2026-01-08T20:19:27Z | 0 | 0 | 0900006480429647 | ||
| FDA-2007-N-0080-0001 | FDA | None FDA-2007-N-0080 | Establishment of Fiscal Year 2008 User Fee Rates for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products | Notice | General Notice | 2007-12-11T05:00:00Z | 2007 | 12 | 2025-08-19T00:31:05Z | E7-24000 | 0 | 0 | 09000064804298e2 | ||
| FDA-2007-N-0266-0001 | FDA | None FDA-2007-N-0266 | Agency Information Collection Activities; Proposed Collection; Comment Request; Reports of Corrections and Removals | Notice | N-Notice | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-11T05:00:00Z | 2008-02-12T04:59:59Z | 2025-08-18T23:08:07Z | E7-23962 | 0 | 0 | 090000648042b37a |
| FDA-2000-P-0152-0010 | FDA | Amend Part 133.3 Re: Milk & Nonfat Milk for Use in Standardization FDA-2000-P-0152 | FDA | Notice | NEC-Notice of Extension | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-10T05:00:00Z | 2008-02-12T04:59:59Z | 2008-04-25T01:44:24Z | 0 | 0 | 09000064804d1371 | |
| FDA-2007-N-0087-0001 | FDA | None FDA-2007-N-0087 | Agency Information Collection Activities; Proposed Collection; Comment Request; Mental Models Study of Communicating With Health Care Providers About the Risks and Benefits of Prescription Drug Use for Pregnant and Nursing Women With Chronic Conditions | Notice | 60 Day Proposed Information Collection | 2007-12-11T05:00:00Z | 2007 | 12 | 2007-12-10T05:00:00Z | 2008-02-12T04:59:59Z | 2025-09-24T22:10:20Z | E7-23976 | 0 | 0 | 0900006480429c98 |
| FDA-2006-N-0239-0007 | FDA | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species FDA-2006-N-0239 | Index of Legally Marketed Unapproved New Animal Drugs for Minor Species; Final Rule | Notice | Notice of Final Rule | 2007-12-06T05:00:00Z | 2007 | 12 | 2007-12-05T05:00:00Z | 2015-12-15T17:50:54Z | 0 | 0 | 0900006480456f42 | ||
| FDA-2007-F-0330-0001 | FDA | None FDA-2007-F-0330 | General Mills, Inc.; Filing of Food Additive Petition (FAP 7M4770) | Notice | NFL-Notice of Filing | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-11-30T05:00:00Z | 2026-01-08T19:37:41Z | 0 | 0 | 090000648042b848 | ||
| FDA-2007-N-0074-0001 | FDA | None FDA-2007-N-0074 | Number not used | Notice | NFL-Notice of Filing | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2008-04-04T00:35:37Z | 0 | 0 | 090000648042988b | ||
| FDA-1995-N-0061-0001 | FDA | CGMP Certain Requirements for Finished Pharmaceuticals FDA-1995-N-0061 | FDA | Notice | NWL-Notice of Withdrawl | 2007-12-04T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2008-05-16T22:33:32Z | 0 | 0 | 090000648056c4d1 | ||
| FDA-2007-N-0443-0003 | FDA | None FDA-2007-N-0443 | FDA | Notice | NFL-Notice of Filing | 2007-12-03T05:00:00Z | 2007 | 12 | 2007-11-30T05:00:00Z | 2008-04-04T00:36:42Z | 0 | 0 | 090000648042ddc0 | ||
| FDA-2007-N-0323-0002 | FDA | None FDA-2007-N-0323 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Type A Medicated Articles | Notice | 30 Day Proposed Information Collection | 2007-12-03T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2008-01-03T04:59:59Z | 2025-07-29T23:35:15Z | E7-23351 | 0 | 0 | 090000648042b7f5 |
| FDA-2007-N-0443-0002 | FDA | None FDA-2007-N-0443 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Color Additive Certification Requests and Recordkeeplng | Notice | 30 Day Proposed Information Collection | 2007-12-03T05:00:00Z | 2007 | 12 | 2007-12-03T05:00:00Z | 2008-01-03T04:59:59Z | 2025-07-28T17:46:21Z | E7-23352 | 0 | 0 | 090000648042ddbe |
| FDA-2005-D-0445-0007 | FDA | Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle, re FDA-2012-N-0115 FDA-2005-D-0445 | Guidance for Industry and Food and Drug Administration Staff: Class II Special Controls Guidance Document: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle; Availability | Notice | Notice of Availability | 2007-11-30T05:00:00Z | 2007 | 11 | 2007-11-30T05:00:00Z | 2015-01-20T23:53:18Z | 0 | 0 | 09000064804505f1 | ||
| FDA-1976-N-0026-0001 | FDA | OTC Antitussives-CLOSED FDA-1976-N-0026 | Cold, Cough, Allergy, Bronchodilator and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amerndment of Final Monograph for OTC Antitussive Drug Products; Technical Amendment - Notice of Final Rule | Notice | NFR-Notice of Final Rule | 2007-11-30T05:00:00Z | 2007 | 11 | 2014-10-14T17:01:15Z | 72 | 0 | 0 | 090000648051b4ed | ||
| FDA-2007-N-0198-0007 | FDA | None FDA-2007-N-0198 | Food Labeling: Use of Symbols to Communicate Nutrition Information, Consideration of Consumer Studies and Nutritional Criteria; Reopening of Comment Period - Notice of Extension | Notice | NEC-Notice of Extension | 2007-11-30T05:00:00Z | 2007 | 11 | 2007-11-30T05:00:00Z | 2008-01-16T04:59:59Z | 2009-03-31T19:50:39Z | 0 | 0 | 090000648042a9d6 | |
| FDA-2005-N-0286-0002 | FDA | Medical Devices; Hematology and Pathology Devices; Reclassification from Class III to Class II of Automated Blood Cell Separator Device Operating by Centrifugal Separation Principle FDA-2005-N-0286 | Medical Devices; Hematology and Pathology Devices; Reclassification of Automated Blood Cell Separator Device Operating by Centrifugal Separation Principle | Notice | Notice of Final Rule | 2007-11-30T05:00:00Z | 2007 | 11 | 2007-11-30T05:00:00Z | 2025-09-16T20:42:17Z | E7-23285 | 0 | 0 | 0900006480445883 | |
| FDA-2007-N-0450-0001 | FDA | None FDA-2007-N-0450 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Registration of Producers of Drugs and Listing of Drugs in Commercial Distribution | Notice | 30 Day Proposed Information Collection | 2007-11-30T05:00:00Z | 2007 | 11 | 2007-11-30T05:00:00Z | 2008-01-01T04:59:59Z | 2025-08-07T23:39:14Z | E7-23275 | 0 | 0 | 090000648042de6d |
| FDA-2006-F-0056-0004 | FDA | Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767) FDA-2006-F-0056 | Secondary Direct Food Additives Permitted in Food for Human Consumption | Notice | Notice of Final Rule | 2007-11-29T05:00:00Z | 2007 | 11 | 2007-11-29T05:00:00Z | 2008-01-01T04:59:59Z | 2026-01-07T18:53:53Z | E7-23182 | 0 | 0 | 090000648044416c |
| FDA-2006-F-0056-0003 | FDA | Safe Use of Cetylpyridinium Chloride as an Antimicrobial Agent in a Pre-chiller or Post-chiller Solution for Application to Raw Poultry Carcasses (FAP 6A4767) FDA-2006-F-0056 | Secondary Direct Food Additives Permitted in Food for Human Consumption | Notice | Notice of Final Rule | 2007-11-29T05:00:00Z | 2007 | 11 | 2007-11-29T05:00:00Z | 2008-01-01T04:59:59Z | 2026-01-07T18:50:12Z | E7-23182 | 0 | 0 | 090000648044416b |
| FDA-1978-N-0018-0612 | FDA | Sunscreen Drug Products -OPEN FDA-1978-N-0018 | Sunscreen Drug Products for Over-The-Counter Human Use; Proposed Amendment of Final Monograph; Extension of Comment Period | Notice | Notice of Extension | 2007-11-28T05:00:00Z | 2007 | 11 | 2007-11-28T05:00:00Z | 2007-12-27T04:59:59Z | 2019-08-01T16:04:23Z | 07-5853 | 0 | 0 | 090000648055c00d |
| FDA-2007-N-0361-0001 | FDA | None FDA-2007-N-0361 | FDA | Notice | NRD-Notice of Requesting Data, Info, & Views | 2007-11-28T05:00:00Z | 2007 | 11 | 2007-11-27T05:00:00Z | 2008-01-29T04:59:59Z | 2008-04-04T00:36:26Z | 0 | 0 | 090000648042ba35 | |
| FDA-2006-P-0006-0004 | FDA | To permit an ANDA Suitability for Eloxatin (Oxaliplatin for injection) FDA-2006-P-0006 | Determination That ELOXATIN (Oxaliplatin for Injection), 50 and 100 Milligrams Per Vial, Sterile Lyophilized Powder for Injection, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness | Notice | N-Notice | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-23T05:00:00Z | 2024-11-14T14:37:17Z | 0 | 0 | 0900006480441444 | ||
| FDA-2006-P-0069-0004 | FDA | ANDA for ELOXATIN (oxaliplatin for injection) lyophilized powder for infusion, 50 mg and 100 mg vials FDA-2006-P-0069 | Notice of Determination | Notice | N-Notice | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-23T05:00:00Z | 2024-11-13T14:49:01Z | 0 | 0 | 0900006480444464 | ||
| FDA-2005-P-0371-0002 | FDA | Nutrient Content Claims for ALA & DHA Omega-3 Fatty Acids FDA-2005-P-0371 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-26T05:00:00Z | 2008-02-12T04:59:59Z | 2008-04-12T00:10:08Z | 0 | 0 | 090000648044b3d9 | |
| FDA-2006-P-0085-0004 | FDA | Determine whether Eloxatin (Oxaliplatin for Injection) has been voluntarily withdrawn or withheld from sale for safety or efficacy reasons FDA-2006-P-0085 | Notice of Determination | Notice | N-Notice | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-23T05:00:00Z | 2024-11-04T19:38:04Z | 0 | 0 | 090000648044498c | ||
| FDA-2007-P-0247-0005 | FDA | None FDA-2007-P-0247 | Determination That ELOXATIN (Oxaliplatin for Injection), 50 and 100 Milligrams Per Vial, Sterile Lyophilized Powder for Injection, Was Not Withdrawn From Saie for Reasons of Safety or Effectiveness | Notice | N-Notice | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-26T05:00:00Z | 2025-03-05T16:57:42Z | E7-22973 | 0 | 0 | 090000648042b113 | |
| FDA-2006-P-0201-0004 | FDA | Determine whether Eloxatin (Oxaliplatin for Injection) 50 mg and 100 mg sterile lyophilized powder vials (NDA #21-492 has been withdrawn for safety or effectiveness reasons FDA-2006-P-0201 | FDA Federal Register announcing the FDA Determination | Notice | N-Notice | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-23T05:00:00Z | 2008-06-19T19:57:27Z | 0 | 0 | 0900006480450f51 | ||
| FDA-2006-P-0224-0003 | FDA | Nutrient Content Claim for EPA and DHA omega-3 fatty acids FDA-2006-P-0224 | FDA | Notice | NPR-Notice of Proposed Rule-Making | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-26T05:00:00Z | 2008-02-12T04:59:59Z | 2008-04-11T23:18:48Z | 0 | 0 | 0900006480456093 | |
| FDA-2007-N-0083-0017 | FDA | None FDA-2007-N-0083 | Behind the Counter Availability of Certain Drugs; Public Meeting; Comment Period Clarification | Notice | NCR-Notice of Correction | 2007-11-27T05:00:00Z | 2007 | 11 | 2007-11-26T05:00:00Z | 2007-12-18T04:59:59Z | 2008-05-12T05:42:58Z | 0 | 0 | 0900006480429a98 | |
| FDA-2007-D-0132-0001 | FDA | None FDA-2007-D-0132 | Draft Guidance for Industry on Smallpox (Variola) Infection: Developing Drugs for Treatment or Prevention | Notice | NAD-Notice of Availability of Data | 2007-11-23T05:00:00Z | 2007 | 11 | 2007-11-21T05:00:00Z | 2008-01-23T04:59:59Z | 2008-08-06T20:00:34Z | 0 | 0 | 090000648042a2b6 | |
| FDA-1999-D-0048-0006 | FDA | Impurities in New Veterinary Medicinal Products; International Cooperation on Harmonisation of Technical Requirements, VICH GL11 FDA-1999-D-0048 | International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Revised Guidance for Industry on Impurities in New Veterinary Medicinal Products (Revision); Availability | Notice | Notice of Data Availability | 2007-11-23T05:00:00Z | 2007 | 11 | 2007-11-21T05:00:00Z | 2008-11-22T04:59:59Z | 2025-06-10T19:14:10Z | E7-22901 | 0 | 0 | 09000064804a6009 |
| FDA-2006-D-0299-0004 | FDA | Stability Testing of New Veterinary Drug Substances and Medicinal Products (Revision) VICH GL3 (R) (#73) FDA-2006-D-0299 | FDA | Notice | NAD-Notice of Availability of Data | 2007-11-23T05:00:00Z | 2007 | 11 | 2007-11-21T05:00:00Z | 2008-11-22T04:59:59Z | 2008-04-11T23:06:36Z | 0 | 0 | 0900006480458fb7 | |
| FDA-1999-D-0064-0005 | FDA | Impurities in New Veterinary Drug Substances FDA-1999-D-0064 | International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Revised Guidance for Industry on Impurities in New Veterinary Drug Substances (Revision); Availability | Notice | Notice of Data Availability | 2007-11-23T05:00:00Z | 2007 | 11 | 2007-11-21T05:00:00Z | 2008-11-22T04:59:59Z | 2025-06-12T19:51:21Z | E7-22902 | 0 | 0 | 09000064804a67af |
| FDA-2004-D-0298-0003 | FDA | Compliance Policy Guide Sec. 400.210 Radiofrequency Identification Feasibility Studies and Pilot Programs for Drugs, Availability FDA-2004-D-0298 | FDA | Notice | NEC-Notice of Extension | 2007-11-23T05:00:00Z | 2007 | 11 | 2007-11-21T05:00:00Z | 2008-04-12T00:35:32Z | 0 | 0 | 0900006480472d20 | ||
| FDA-2007-N-0154-0001 | FDA | None FDA-2007-N-0154 | Agency Information Collection Activities; Proposed Collection; Comment Request; Recordkeeping and Records Access Requirements for Food Facilities | Notice | 60 Day Proposed Information Collection | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-19T05:00:00Z | 2008-01-19T04:59:59Z | 2025-08-15T21:26:09Z | E7-22480 | 0 | 0 | 090000648042a457 |
| FDA-2006-F-0313-0001 | FDA | Safe Use of Poly (iminoimidocarbonyliminoimidocarbonyliminohexamethylene) Hydrochloride (CAS Reg No. 32289-58-0) as an Antimicrobial Agent in the Manufacture of Food-Contact Paper and Paperboard (FAP 6B4764) FDA-2006-F-0313 | ARCH Chemicals, Inc.; Withdrawal of Food Additive Petition FAP 6B4764 | Notice | Withdrawal | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-19T05:00:00Z | 2025-12-17T19:50:52Z | E7-22536 | 0 | 0 | 090000648045c904 | |
| FDA-2007-N-0447-0003 | FDA | None FDA-2007-N-0447 | FDA | Notice | N-Notice | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-16T05:00:00Z | 2008-04-04T00:36:45Z | 0 | 0 | 090000648042de13 | ||
| FDA-2007-N-0037-0002 | FDA | None FDA-2007-N-0037 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animal Drug User Fees and Fee Waivers and Reductions | Notice | 30 Day Proposed Information Collection | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-19T05:00:00Z | 2007-12-20T04:59:59Z | 2025-07-23T16:02:33Z | E7-22495 | 0 | 0 | 09000064804295db |
| FDA-2007-N-0217-0002 | FDA | None FDA-2007-N-0217 | Agency Information Collection Activities: Submission for Office of Management and Budget Review; Comment Request; Medical Devices Third-Party Review Under the Food and Drug Administration Modernization Act | Notice | 30 Day Proposed Information Collection | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-19T05:00:00Z | 2007-12-20T04:59:59Z | 2025-07-23T18:31:50Z | E7-22586 | 0 | 0 | 090000648042add2 |
| FDA-2007-N-0264-0002 | FDA | None FDA-2007-N-0264 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Voluntary Registration of Cosmetic Product Establishments | Notice | 30 Day Proposed Information Collection | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-19T05:00:00Z | 2007-12-20T04:59:59Z | 2025-07-28T17:12:07Z | E7-22588 | 0 | 0 | 090000648042b346 |
| FDA-2007-N-0085-0001 | FDA | None FDA-2007-N-0085 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Regulations for Medicated Feeds | Notice | 30 Day Proposed Information Collection | 2007-11-20T05:00:00Z | 2007 | 11 | 2025-07-29T23:04:30Z | 0 | 0 | 0900006480429c7e | |||
| FDA-2007-N-0267-0001 | FDA | None FDA-2007-N-0267 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Animal Drug User Fee Cover Sheet, FDA Form 3546 | Notice | 30 Day Proposed Information Collection | 2007-11-20T05:00:00Z | 2007 | 11 | 2007-11-20T05:00:00Z | 2007-12-21T04:59:59Z | 2025-07-23T16:52:02Z | E7-22649 | 0 | 0 | 090000648042b383 |
| FDA-2007-N-0039-0001 | FDA | None FDA-2007-N-0039 | Agency Emergency Processing Under Office of Management and Budget Review; Orphan Drug Products; Common European Medicines Evaluation Agency/Food and Drug Administration Application Form for Orphan Medicinal Product Designation | Notice | General Notice | 2007-11-09T05:00:00Z | 2007 | 11 | 2007-11-09T05:00:00Z | 2007-11-20T04:59:59Z | 2025-08-15T18:39:29Z | E7-21988 | 0 | 0 | 09000064804295f2 |
| FDA-2007-M-0389-0001 | FDA | None FDA-2007-M-0389 | Medical Devices Regulated by the Center for Biologics Evaluation and Research; Availability of Summaries of Safety and Effectiveness Data for Premarket Approval Applications | Notice | Notice of Data Availability | 2007-11-09T05:00:00Z | 2007 | 11 | 2007-11-09T05:00:00Z | 2026-01-13T02:23:08Z | E7-21986 | 0 | 0 | 090000648042d7c1 | |
| FDA-2007-N-0428-0001 | FDA | None FDA-2007-N-0428 | Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Participation in the Medical Device Fellowship Program | Notice | 60 Day Proposed Information Collection | 2007-11-09T05:00:00Z | 2007 | 11 | 2007-11-09T05:00:00Z | 2008-01-09T04:59:59Z | 2025-08-15T16:40:31Z | E7-21971 | 0 | 0 | 090000648042dc01 |
| FDA-2007-D-0133-0001 | FDA | None FDA-2007-D-0133 | See FDA-2007-D-0133-0003 | Notice | 2007-11-09T00:00:00Z | 2007 | 11 | 2008-05-28T00:54:44Z | 0 | 1 | 090000648042a2c0 | ||||
| FDA-2007-N-0314-0010 | FDA | None FDA-2007-N-0314 | Use of Ozone-Depleting Substances; Removal of Essential-Use Designation (Epinephrine) - Notice of Public Meeting and Extension of Comment Period | Notice | NEC-Notice of Extension | 2007-11-08T05:00:00Z | 2007 | 11 | 2007-11-08T05:00:00Z | 2007-12-20T04:59:59Z | 2008-11-19T13:48:39Z | 0 | 0 | 090000648042b762 | |
| FDA-2007-N-0073-0001 | FDA | None FDA-2007-N-0073 | Lederle Laboratories et al.; Withdrawal of Approval of 73 New Drug Applications and 62 Abbreviated New Drug Applications | Notice | Withdrawal | 2007-11-08T05:00:00Z | 2007 | 11 | 2025-09-16T21:26:14Z | E7-21886 | 0 | 0 | 0900006480429885 | ||
| FDA-2007-N-0197-0001 | FDA | None FDA-2007-N-0197 | Adolescent Over-the-Counter Drug Product Use; Public Workshop | Notice | Meeting | 2007-11-05T04:00:00Z | 2007 | 11 | 2007-11-05T05:00:00Z | 2008-02-01T04:59:59Z | 2025-09-16T18:54:47Z | E7-21713 | 0 | 0 | 090000648042a932 |
| FDA-2002-D-0094-0003 | FDA | Disclosure of Conflicts of Interest for Special Government Employees FDA-2002-D-0094 | Draft Guidance for the Public, Food and Drug Administration Advisory Committee Members, and Food and Drug Administration Staff: Public Availability of Advisory Committee Members Financial Interest Information and Waivers; Availability | Notice | NAD-Notice of Availability of Data | 2007-10-31T04:00:00Z | 2007 | 10 | 2007-10-31T04:00:00Z | 2008-01-01T04:59:59Z | 2010-08-06T23:52:22Z | 0 | 0 | 090000648048e4a5 | |
| FDA-2007-D-0375-0001 | FDA | None FDA-2007-D-0375 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-30T04:00:00Z | 2007 | 10 | 2007-10-29T04:00:00Z | 2008-01-29T04:59:59Z | 2008-07-21T19:57:16Z | 0 | 0 | 090000648042c89d | |
| FDA-2007-F-0046-0002 | FDA | None FDA-2007-F-0046 | Biomin GmbH; Filing of Food Additive Petition | Notice | Notice of Filing | 2007-10-30T04:00:00Z | 2007 | 10 | 2007-10-29T04:00:00Z | 2008-01-01T04:59:59Z | 2026-01-03T00:16:28Z | 0 | 0 | 090000648042965e | |
| FDA-2005-D-0211-0050 | FDA | Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease Indications FDA-2005-D-0211 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-29T04:00:00Z | 2007 | 10 | 2007-10-26T04:00:00Z | 2008-04-11T23:46:52Z | 0 | 0 | 0900006480441500 | ||
| FDA-2007-D-0069-0001 | FDA | None FDA-2007-D-0069 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-29T04:00:00Z | 2007 | 10 | 2007-10-26T04:00:00Z | 2008-01-29T04:59:59Z | 2008-04-04T00:34:03Z | 0 | 0 | 0900006480429834 | |
| FDA-2007-D-0367-0001 | FDA | None FDA-2007-D-0367 | Draft Guidance for Industry and Food and Drug Administration Staff; Impact Resistant Lenses: Questions and Answers; Availability | Notice | NAD-Notice of Availability of Data | 2007-10-26T04:00:00Z | 2007 | 10 | 2007-10-26T04:00:00Z | 2008-01-25T04:59:59Z | 2008-05-19T23:59:38Z | 0 | 0 | 090000648042bb4e | |
| FDA-2003-N-0441-0002 | FDA | Exocrine Pancreatic Insufficiency Drug Products FDA-2003-N-0441 | Exocrine Pancreatic Insufficiency Drug Products; Extension to Obtain Marketing Approval | Notice | General Notice | 2007-10-26T04:00:00Z | 2007 | 10 | 2007-10-26T04:00:00Z | 2025-03-05T19:50:55Z | E7-21082 | 0 | 0 | 09000064804a245c | |
| FDA-2007-D-0309-0001 | FDA | None FDA-2007-D-0309 | Drug-Induced Liver Injury; Premarketing Clinical Evaluation; Draft Guidance | Notice | NAD-Notice of Availability of Data | 2007-10-25T04:00:00Z | 2007 | 10 | 2007-10-25T04:00:00Z | 2007-12-25T04:59:59Z | 2008-08-27T17:27:07Z | 72FR60681 | 0 | 0 | 090000648042b6c1 |
| FDA-2006-N-0176-0003 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry on Continuous Marketing Applications: Pilot 2 - Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act FDA-2006-N-0176 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Continuous Marketing Applications: Pilot- Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act | Notice | Notice of Approval | 2007-10-25T04:00:00Z | 2007 | 10 | 2007-10-25T04:00:00Z | 2025-06-20T17:24:04Z | E7-21056 | 0 | 0 | 0900006480450b60 | |
| FDA-2007-N-0446-0001 | FDA | None FDA-2007-N-0446 | User Fee Program for Advisory Review of Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products; Request for Notification of Participation and Number of Advertisements for Review | Notice | General Notice | 2007-10-25T04:00:00Z | 2007 | 10 | 2007-10-25T04:00:00Z | 2007-11-27T04:59:59Z | 2025-08-14T18:54:22Z | 07-5282 | 0 | 0 | 090000648042de03 |
| FDA-2007-D-0369-0002 | FDA | None FDA-2007-D-0369 | Publication of Guidances for Industry Describing Product-Specific Bioequivalence Recommendations | Notice | NAD-Notice of Availability of Data | 2007-10-25T04:00:00Z | 2007 | 10 | 2007-10-25T04:00:00Z | 2007-12-25T04:59:59Z | 2008-05-20T19:33:47Z | 0 | 0 | 090000648042bb9e | |
| FDA-1999-N-0114-0007 | FDA | Current Good Manufacturing Practice for Blood & Blood Components; Notification of Consignees & Transfusion Recipients Receiving Blood & Blood Components at Increased Risk of Transmitting Hepatitis C Virus Infection ("Lookback") FDA-1999-N-0114 | Notice of Approval re Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; CGMP for Blood and Blood Components; Notification of Consignees and Transfusion Recipients Receiving Blood and Blood Components at Increased Risk of Transmitting HCV Infection ("Lookback") | Notice | Notice of Approval | 2007-10-25T04:00:00Z | 2007 | 10 | 2007-10-25T04:00:00Z | 2024-10-03T21:46:36Z | 72FR48766 | 0 | 0 | 09000064804ae8e8 | |
| FDA-2007-D-0076-0001 | FDA | None FDA-2007-D-0076 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-25T04:00:00Z | 2007 | 10 | 2007-10-25T04:00:00Z | 2008-01-24T04:59:59Z | 2008-04-04T00:34:05Z | 0 | 0 | 090000648042989f | |
| FDA-2006-N-0111-0004 | FDA | Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer (DTC) Print Advertisements for Prescription Drugs FDA-2006-N-0111 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer Print Advertisements for Prescription Drugs | Notice | Notice of Approval | 2007-10-24T04:00:00Z | 2007 | 10 | 2007-10-22T04:00:00Z | 2025-06-16T16:28:20Z | E7-20756 | 0 | 0 | 09000064804500c3 | |
| FDA-2007-D-0258-0001 | FDA | None FDA-2007-D-0258 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-24T04:00:00Z | 2007 | 10 | 2007-10-18T04:00:00Z | 2008-04-04T00:34:20Z | 0 | 0 | 090000648042b1ca | ||
| FDA-2007-N-0363-0015 | FDA | None FDA-2007-N-0363 | FDA | Notice | N-Notice | 2007-10-24T04:00:00Z | 2007 | 10 | 2007-10-19T04:00:00Z | 2007-12-07T04:59:59Z | 2008-04-04T00:36:28Z | 0 | 0 | 090000648042bacf | |
| FDA-2007-P-0108-0004 | FDA | None FDA-2007-P-0108 | Nonprescription Drugs Advisory Committee; Notice of Meeting | Notice | Meeting | 2007-10-24T04:00:00Z | 2007 | 10 | 2007-10-24T04:00:00Z | 2007-12-31T04:59:59Z | 2025-07-09T23:09:12Z | 07-5249 | 0 | 0 | 0900006480429e46 |
| FDA-2006-D-0168-0010 | FDA | Guidance for Industry: Guide to Minimize Food Safety Hazards for Fresh-cut Fruits and Vegetables FDA-2006-D-0168 | FDA | Notice | NAL-Notice of Approval | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-19T04:00:00Z | 2008-04-11T23:03:24Z | 0 | 0 | 09000064804508f8 | ||
| FDA-2007-D-0028-0001 | FDA | None FDA-2007-D-0028 | FDA | Notice | NAD-Notice of Availability of Data | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-19T04:00:00Z | 2008-04-04T00:34:00Z | 0 | 0 | 09000064804294a1 | ||
| FDA-2007-N-0082-0002 | FDA | None FDA-2007-N-0082 | Revision of the Requirements for Live Vaccine Processing | Notice | Notice of Final Rule | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-17T04:00:00Z | 2008-01-03T04:59:59Z | 2025-07-29T17:31:25Z | E7-20610 | 0 | 0 | 0900006480429902 |
| FDA-2000-N-0143-0002 | FDA | Proposed Revision of Postmarketing Reporting Requirements FDA-2000-N-0143 | Applications for Food and Drug Administration Application Approval to Market a New Drug; Revision of Postmarketing Reporting Requirements | Notice | Notice of Final Rule | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-18T04:00:00Z | 2025-06-13T00:26:00Z | E7-20510 | 0 | 0 | 09000064804d0dec | |
| FDA-2007-N-0362-0001 | FDA | None FDA-2007-N-0362 | FDA | Notice | N-Notice | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-19T04:00:00Z | 2008-04-04T00:36:26Z | 0 | 0 | 090000648042ba40 | ||
| FDA-2007-N-0082-0001 | FDA | None FDA-2007-N-0082 | Revision of the Requirements for Live Vaccine Processing; Companion to Direct Final Rule | Notice | NPR-Notice of Proposed Rule-Making | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-18T04:00:00Z | 2008-01-03T04:59:59Z | 2025-07-30T09:00:20Z | E7-20609 | 0 | 0 | 09000064804298fe |
| FDA-2007-N-0216-0002 | FDA | None FDA-2007-N-0216 | FDA | Notice | N-Notice | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-19T04:00:00Z | 2008-10-21T03:59:59Z | 2008-04-04T00:36:03Z | 0 | 0 | 090000648042adc3 | |
| FDA-2000-D-0221-0007 | FDA | Guidance for Industry: Special Protocol Assessment FDA-2000-D-0221 | FDA | Notice | NAL-Notice of Approval | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-17T04:00:00Z | 2008-04-25T01:14:34Z | 0 | 0 | 09000064804d5177 | ||
| FDA-2007-D-0420-0001 | FDA | None FDA-2007-D-0420 | Draft Guidance for Industry on the Use of Mechanical Calibration of Dissolution Apparatus 1 and 2 Current Good Manufacturing Practice; Availability | Notice | NAD-Notice of Availability of Data | 2007-10-19T04:00:00Z | 2007 | 10 | 2007-10-19T04:00:00Z | 2007-12-19T04:59:59Z | 2008-04-19T00:59:52Z | 0 | 0 | 090000648042dab4 | |
| FDA-2007-N-0388-0004 | FDA | None FDA-2007-N-0388 | Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Toll-Free Number for Consumer Reporting of Drug Product Side Effects: Comprehension | Notice | Notice of Approval | 2007-10-17T04:00:00Z | 2007 | 10 | 2025-07-01T23:39:15Z | E7-20075 | 0 | 0 | 090000648042d7b8 | ||
| FDA-2001-D-0045-0002 | FDA | Guidance for Industry - Yellow Corn & Dry-Milled FDA-2001-D-0045 | FDA | Notice | N-Notice | 2007-10-17T04:00:00Z | 2007 | 10 | 2007-10-17T04:00:00Z | 2007-12-18T04:59:59Z | 2008-04-25T01:57:24Z | 0 | 0 | 09000064804b7519 | |
| FDA-2007-N-0040-0002 | FDA | None FDA-2007-N-0040 | Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Institutional Review Boards | Notice | 30 Day Proposed Information Collection | 2007-10-17T04:00:00Z | 2007 | 10 | 2007-10-11T04:00:00Z | 2007-11-14T04:59:59Z | 2025-07-23T23:25:29Z | E7-20063 | 0 | 0 | 0900006480429604 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;